Aristotle University Of Thessaloniki (AUTH)
Μελέτη έκφρασης γονιδίων που σχετίζονται με την υποξία των όγκων στον καρκίνο του νεφρού
Abstract
dc:descriptionKidney cancer accounts for 2‑3% of all malignancies in adults and is the 12th most common cancer type worldwide. Cancer cells, with their specific genetic and epigenetic mechanisms, can adapt to these hypoxic conditions. This is partly achieved by regulation of gene products in response to hypoxia. A number of these hypoxia‑regulated genes require the mediation of hypoxia inducible factors (HIF). Under normoxia condition, HIF‑1α and HIF‑2α are continuously expressed and degraded. Degradation is mediated by the prolyl hydroxylases (PHD). The present study investigated the possible involvement of the HIF/PHD pathway in RCC by evaluating HIF‑1α, HIF‑2α, PHD1, PHD2 and PHD3 mRNA expression levels using real time quantitative PCR (qPCR). In addition, as little is known about the hypoxia pathway in a large group of benign kidney tumours, the oncocytomas, we compared the expression differences in the HIF/PHD pathway between ccRCC and oncocytomas. Quantitative PCR was used to quantify the mRNA expression levels of HIF‑1α, HIF‑2α, prolyl hydroxylase (PHD)1, PHD2 and PHD3 in both formalin‑fixed paraffin‑embedded (FFPE) and fresh frozen tumour tissue samples from 48 patients, including 41 cases of RCC and 7 cases of oncocytoma. Samples of corresponding adjacent normal kidney tissues for each individual were used as a comparison. mRNA expression levels were analysed regarding clinical parameters, histological type, stage, nuclear grade, cancer specific survival and overall survival. PHD3 mRNA overexpression was recorded in 87.87% (29/33) of the ccRCC FFPE samples. HIF‑1α levels were decreased in 16/33 (48.48%) cases of ccRCC, while HIF‑2α did not exhibit a specific pattern. In addition, PHD1 and PHD2 transcript levels were similar in the majority of patients. With regard to pathological parameters, PHD3 expression levels were inversely associated with Fuhrman grade (P=0.015) in ccRCC cases. No other association was recorded between mRNA expression levels and tumour stage, presence of necrotic or presence of sarcomatous elements. Regarding the oncocytoma cases, 71.45% of cases showed low, with the remaining cases showing medium expression levels of PHD3. There was no difference in expression levels for HIF-1α, HIF-2α, PHD1 and PHD2 between RCC and oncocytoma. In comparison with oncocytoma cases, PHD3 mRNA levels were significantly upregulated (P<0.001) in ccRCC. To the best of our knowledge, this is the first study to identify a correlation between PHD3 expression level and the aggressiveness of tumour cells, suggesting a crucial involvement of PHD3 in ccRCC. The central role of PHD3 in the carcinogenesis of ccRCC is further revealed by the findings of the present study. When the expression of the five interrogated genes (HIF-1α, HIF-2α, PHD1, PHD2 and PHD3) was compared between oncocytomas and ccRCC, only PHD3 was found to be significantly upregulated in ccRCC, identifying the upregulation of PHD3 as the possible underlying difference in the behaviour of ccRCC. In conclusion, the present study demonstrated that PHD3 may play an important role in the valuable host molecular adaptation that occurs during oxidative stress in ccRCC.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kampantais, Spyridon
- Καμπάνταης, Σπυρίδων
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48351